Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Imaging Studies for Cardiovascular System IV: CMRI
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 6, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
P Puech1, A Sufana-Iancu, B Renard
1Department of Uroradiology, Lille Hospital, 1, rue Michel-Polonovski, 59037 Lille cedex, France; University of Lille Nord de France, Lille 59800, France; Inserm U703, 59120 Loos, France.
Dynamic contrast-enhanced (DCE) MRI sequences for prostate cancer detection are debated. While potentially redundant, they offer unique insights into lesion visibility, cancer staging, and recurrence detection, crucial for treatment decisions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: